Skip to content

Prospective multicenter validation and optimization of the ''Drum Tower severity scoring system'' for hepatic sinus obstruction syndrome

Prospective multicenter validation and optimization of the ''Drum Tower severity scoring system'' for hepatic sinus obstruction syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061760
Enrollment
Unknown
Registered
2022-07-02
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic sinusoidal obstruction syndrome

Interventions

Gold Standard:Definition of non response to anticoagulation: 1. during the follow-up of anticoagulation therapy, total bilirubin >= 5mg/dl, or portal vein velocity < 10cm/s
2. Or meet any 2 of the following 4 items within 2 weeks after the start of anticoagulation treatment: (1) Bilirubin 1<= x <5mg/dl but <10%
Index test:Drum&#32
system

Sponsors

The Affiliated Drum Tower Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. It is definitely diagnosed as PA-HSOS according to "Nanjing standard"; 2. Aged from 18 to 85; 3. Did not receive anticoagulation and tips treatment before inclusion; 4. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. There were 2 or more other liver damage factors in the past, such as drinking, hepatotropic virus infection, autoimmune liver disease, etc; Chronic portal hypertension (with collateral circulation such as esophageal and gastric varices) existed in patients with acute onset; 2. Contraindications associated with anticoagulant therapy, such as active bleeding, recent history of internal organ bleeding, severe abnormal bleeding and coagulation mechanism, etc; 3. Previous history of malignant tumor.

Design outcomes

Primary

MeasureTime frame
C-index;Sensitivity;Specificity;

Countries

China

Contacts

Public ContactYuzheng Zhuge

The Affiliated Drum Tower Hospital of Nanjing University Medical School

yuzheng9111963@aliyun.com+86 15996289206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026